Abiopharma

News list

Godbout Sean 🟡 adjusted position in 54 shares (1 derivative) of BIOGEN INC. (BIIB) at $183.78 Transaction Date: Apr 01, 2026 | Filing ID: 000036

Full text

News bot April 3, 2026, 8:06 p.m.
🔍 Godbout Sean (Executive)

Company: BIOGEN INC. (BIIB)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 181
- Total shares sold: 235
Detailed Transactions and Holdings:
- Acquired 181 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,395.67 | transaction_form_type: 4
- Sold 54 shares of Common Stock at $183.78 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,341.67 | transaction_form_type: 4
- Sold 181 shares of Restricted Stock Unit (Derivative)
  Date: 2026-04-01 | Code: M | Expires: 2028-04-01 | equity_swap_involved: 0 | shares_owned_after: 364.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of April 1, 2025.